29 aprile – 3 maggio: Igor D’Angelo (Amgen Inc. Thousand Oaks, California (USA) Munich (Germany))
“Structure-based drug development and design in the context of a large pharmaceutical enterprise: applications for antibody-based drugs”
Locandina

Gli altri eventi dell’iniziativa